rs11710456

This is a intron variant variant in the ST6GAL1 gene.

GWAS Catalog Trait Associations (10)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

IgG galactosylation measurement

Allele A
OR
p 2.0e-90
N 1,960
Large GWAS
European

IgG fucosylation measurement

Allele A
OR
p 1.0e-88
N 1,960
Large GWAS
European

serum IgG glycosylation measurement

Allele G
OR
p 6.0e-87
N 1,960
Large GWAS
European
Allele G
OR 0.50
p 2.0e-45
N 2,247
Large GWAS
European
Landini A et al. Genetic regulation of post-translational modification of two distinct proteins. Nature Communications 13(1):1586 (2022)
Allele G
OR 0.60
p 2.0e-69
N 2,020
Large GWAS
European
Allele G
OR 0.22
p 1.0e-8
N 1,823
Large GWAS
European

IgG digalactosylation measurement

Allele A
OR
p 5.0e-79
N 1,960
Large GWAS
European

IgG monogalactosylation measurement

Allele A
OR
p 3.0e-69
N 1,960
Large GWAS
European

IgG sialylation measurement

Allele A
OR
p 2.0e-51
N 1,960
Large GWAS
European

IgG monosialylation measurement

Allele A
OR
p 7.0e-42
N 1,960
Large GWAS
European

IgG disialylation measurement

Allele A
OR
p 2.0e-13
N 1,960
Large GWAS
European

N-glycan measurement

Allele A
OR 0.43
p 3.0e-127
N 7,540
Large GWAS
multi-ancestry

About ST6GAL1

This gene encodes a member of glycosyltransferase family 29. The encoded protein is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The protein, which is normally found in the Golgi but can be proteolytically processed to a soluble form, is involved in the generation of the cell-surface carbohydrate determinants and differentiation antigens HB-6, CD75, and CD76. This gene has been incorrectly referred to as CD75. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]

View all ST6GAL1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…